HIV-1 protease inhibitors

AIDS Clin Rev. 1997:145-85. doi: 10.1001/jama.1997.03540260059037.
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic / statistics & numerical data
  • Drug Design
  • Drug Interactions
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Indinavir / adverse effects
  • Indinavir / pharmacokinetics
  • Indinavir / therapeutic use
  • Isoquinolines / adverse effects
  • Isoquinolines / pharmacokinetics
  • Isoquinolines / therapeutic use
  • Nelfinavir
  • Ritonavir / adverse effects
  • Ritonavir / pharmacokinetics
  • Ritonavir / therapeutic use
  • Saquinavir / adverse effects
  • Saquinavir / pharmacokinetics
  • Saquinavir / therapeutic use
  • Sulfonic Acids / adverse effects
  • Sulfonic Acids / pharmacokinetics
  • Sulfonic Acids / therapeutic use

Substances

  • HIV Protease Inhibitors
  • Isoquinolines
  • Sulfonic Acids
  • Indinavir
  • Nelfinavir
  • Saquinavir
  • Ritonavir